↓ Skip to main content

Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue

Overview of attention for article published in International Journal of Biochemistry & Cell Biology, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter
20 X users
facebook
5 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
146 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue
Published in
International Journal of Biochemistry & Cell Biology, August 2014
DOI 10.1016/j.biocel.2014.08.007
Pubmed ID
Authors

Patrick McDonough, Joseph P. McKenna, Christine McCreary, Eric J. Downer

Abstract

Neuropathic orofacial pain (NOP) exists in several forms including pathologies such as burning mouth syndrome (BMS), persistent idiopathic facial pain (PIFP), trigeminal neuralgia (TN) and postherpetic neuralgia (PHN). BMS and PIFP are classically diagnosed by excluding other facial pain syndromes. TN and PHN are most often diagnosed based on a typical history and presenting pain characteristics. The pathophysiology of some of these conditions is still unclear and hence treatment options tend to vary and include a wide variety of treatments including cognitive behaviour therapy, anti-depressants, anti-convulsants and opioids; however such treatments often have limited efficacy with a great amount of inter-patient variability and poorly tolerated side effects. Analgesia is one the principal therapeutic targets of the cannabinoid system and many studies have demonstrated the efficacy of cannabinoid compounds in the treatment of neuropathic pain. This review will investigate the potential use of cannabinoids in the treatment of symptoms associated with NOP.

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Italy 1 <1%
Unknown 143 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 16%
Student > Bachelor 24 16%
Student > Master 15 10%
Student > Postgraduate 14 10%
Other 9 6%
Other 23 16%
Unknown 37 25%
Readers by discipline Count As %
Medicine and Dentistry 57 39%
Biochemistry, Genetics and Molecular Biology 10 7%
Psychology 7 5%
Agricultural and Biological Sciences 5 3%
Neuroscience 5 3%
Other 22 15%
Unknown 40 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2018.
All research outputs
#2,417,968
of 25,450,869 outputs
Outputs from International Journal of Biochemistry & Cell Biology
#93
of 2,862 outputs
Outputs of similar age
#24,196
of 247,605 outputs
Outputs of similar age from International Journal of Biochemistry & Cell Biology
#2
of 43 outputs
Altmetric has tracked 25,450,869 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,862 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,605 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.